The following table shows the list of Horizon 2020 projects developed by "PFIZER LIMITED". Projects are ordered by starting date.
Click on table headers to rearrange data.
# | acronym | programme | role | EC contrib. | start | views |
---|---|---|---|---|---|---|
1 | CRYDIS | H2020-EU.1.3.3. | participant | 27˙000.00 | 2015-01-01 | 625 |
2 | ADAPT-SMART | H2020-EU.3.1.7.13. | participant | 0.00 | 2015-07-01 | 688 |
3 | PRISM | H2020-EU.3.1.7. | participant | 0.00 | 2016-04-01 | 829 |
4 | PREFER | H2020-EU.3.1.7. | participant | 0.00 | 2016-10-01 | 645 |
5 | RESCEU | H2020-EU.3.1.7. | participant | 0.00 | 2017-01-01 | 761 |
6 | DO-IT | H2020-EU.3.1.7. | participant | 0.00 | 2017-02-01 | 1014 |
7 | IB4SD-TRISTAN | H2020-EU.3.1.7. | participant | 0.00 | 2017-01-01 | 935 |
8 | ITCC-P4 | H2020-EU.3.1.7. | participant | 0.00 | 2017-01-01 | 11432 |
9 | EQIPD | H2020-EU.3.1.7. | participant | 0.00 | 2017-10-01 | 753 |
10 | RTCure | H2020-EU.3.1.7. | participant | 0.00 | 2017-09-01 | 940 |
11 | LITMUS | H2020-EU.3.1.7. | participant | 0.00 | 2017-11-01 | 1039 |
12 | COMBACTE-CDI | H2020-EU.3.1.7. | participant | 0.00 | 2017-11-01 | 712 |
13 | PARADIGM | H2020-EU.3.1.7. | participant | 0.00 | 2018-03-01 | 582 |
14 | ReSOLUTE | H2020-EU.3.1.7. | participant | 0.00 | 2018-07-01 | 329 |
15 | EFOEUPATI | H2020-EU.3.1.7. | participant | 0.00 | 2018-09-01 | 288 |
16 | WEB-RADR 2 | H2020-EU.3.1.7. | participant | 0.00 | 2018-09-01 | 296 |
17 | iConsensus | H2020-EU.3.1.7. | participant | 0.00 | 2018-05-01 | 316 |
18 | c4c | H2020-EU.3.1.7. | participant | 0.00 | 2018-05-01 | 375 |
19 | IM2PACT | H2020-EU.3.1.7. | participant | 0.00 | 2019-01-01 | 301 |
20 | EHDEN | H2020-EU.3.1.7. | participant | 0.00 | 2018-11-01 | 340 |
21 | VITAL | H2020-EU.3.1.7. | participant | 0.00 | 2019-01-01 | 271 |
22 | NeuroDeRisk | H2020-EU.3.1.7. | participant | 0.00 | 2019-03-01 | 296 |
23 | BIOMAP | H2020-EU.3.1.7. | participant | 0.00 | 2019-04-01 | 315 |
24 | TransBioLine | H2020-EU.3.1.7. | participant | 0.00 | 2019-02-01 | 285 |
25 | MOBILISE-D | H2020-EU.3.1.7. | participant | 0.00 | 2019-04-01 | 371 |
26 | ConcePTION | H2020-EU.3.1.7. | participant | 0.00 | 2019-04-01 | 356 |
27 | EBiSC2 | H2020-EU.3.1.7. | participant | 0.00 | 2019-03-01 | 351 |
28 | Trials@Home | H2020-EU.3.1.7. | participant | 0.00 | 2019-09-01 | 307 |
29 | 3TR | H2020-EU.3.1.7. | participant | 0.00 | 2019-09-01 | 337 |
30 | Immune-Image | H2020-EU.3.1.7. | participant | 0.00 | 2019-10-01 | 381 |
31 | EU-PEARL | H2020-EU.3.1.7. | participant | 0.00 | 2019-11-01 | 315 |
32 | IDEA-FAST | H2020-EU.3.1.7. | participant | 0.00 | 2019-11-01 | 315 |
33 | ImmUniverse | H2020-EU.3.1.7. | participant | 0.00 | 2020-01-01 | 329 |
34 | PharmaLedger | H2020-EU.3.1.7. | participant | 0.00 | 2020-01-01 | 390 |
totale | 27˙000.00 |
This organization collaborated with partners in 32 countries.
Within the project CRYDIS this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
participant | UK | PARAYTEC | PARAYTEC LIMITED (PRC) |
participant | UK | Sirius | PION INC.(UK) LTD (PRC) |
participant | IE | UCC | UNIVERSITY COLLEGE CORK - NATIONAL UNIVERSITY OF IRELAND, CORK (HES) |
coordinator | DK | UCPH | KOBENHAVNS UNIVERSITET (HES) |
Within the project ADAPT-SMART this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
participant | CH | SHIRE | SHIRE INTERNATIONAL GMBH (PRC) |
participant | UK | AbbVie | AbbVie Ltd (PRC) |
participant | BE | UCB | UCB BIOPHARMA SRL (PRC) |
participant | IT | AIFA | AGENZIA ITALIANA DEL FARMACO (PRC) |
participant | FR | Lysogene | LYSOGENE (PRC) |
participant | BE | EFPIA | FEDERATION EUROPEENNE D'ASSOCIATIONS ET D'INDUSTRIES PHARMACEUTIQUES (OTH) |
participant | UK | Astellas | ASTELLAS PHARMA EUROPE LTD (PRC) |
participant | NL | ZIN | ZORGINSTITUUT NEDERLAND (PUB) |
participant | FR | IPSEN | IPSEN INNOVATION SAS (PRC) |
participant | FR | HAS | HAUTE AUTORITE DE SANTE (PUB) |
participant | FR | EURORDIS | EURORDIS - EUROPEAN ORGANISATION FOR RARE DISEASES ASSOCIATION (OTH) |
participant | US | MSD | MERCK SHARP & DOHME CORP (PRC) |
participant | UK | NICE | NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE (PUB) |
participant | US | BMS | BRISTOL-MYERS SQUIBB COMPANY CORP (PRC) |
participant | BE | Amgen | AMGEN (PRC) |
participant | UK | Eli Lilly | Eli Lilly and Company Limited (PRC) |
participant | UK | EMA | THE EUROPEAN MEDICINES AGENCY (PUB) |
coordinator | NL | LYGATURE | STICHTING LYGATURE (OTH) |
participant | FR | IRIS | INSTITUT DE RECHERCHES INTERNATIONALES SERVIER (PRC) |
participant | DE | Bayer | Bayer Pharma AG (PRC) |
participant | US | MIT | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (HES) |
participant | FR | SARD | SANOFI-AVENTIS RECHERCHE & DEVELOPPEMENT (PRC) |
participant | DE | BI | BOEHRINGER INGELHEIM INTERNATIONALGMBH (PRC) |
participant | BE | JANSSEN | JANSSEN PHARMACEUTICA NV (PRC) |
participant | DK | DHMA | SUNDHEDSSTYRELSEN (PUB) |
participant | LU | EPF | FORUM EUROPEEN DES PATIENTS (FPE) (OTH) |
participant | CH | ROCHE | F. HOFFMANN-LA ROCHE AG (PRC) |
participant | CH | NOVARTIS | NOVARTIS PHARMA AG (PRC) |
participant | DK | Lundbeck | H. LUNDBECK AS (PRC) |
participant | UK | GSK | GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT LTD. (PRC) |
participant | DK | Novo Nordisk | NOVO NORDISK A/S (PRC) |
participant | SE | MEDIMMUNE | ASTRAZENECA AB (PRC) |
participant | DE | Merck | MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN (PRC) |
participant | UK | UOXF | THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD (HES) |
Within the project PRISM this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
participant | NL | VUmc | STICHTING VUMC (REC) |
participant | NL | ECNP | STICHTING BURO ECNP (OTH) |
participant | NL | DTID | DRUG TARGET ID BV (PRC) |
participant | FR | BIOTRIAL | BIOTRIAL (PRC) |
participant | UK | SBG | SBGNEURO LTD (PRC) |
participant | UK | P1vital | P1VITAL LIMITED (PRC) |
participant | UK | Takeda EU | TAKEDA DEVELOPMENT CENTRE EUROPE LTD (PRC) |
participant | DE | concentris | Concentris Research Management GmbH (PRC) |
participant | BE | EUFAMI | EUROPESE FEDERATIE VAN FAMILIEVERENIGINGEN VAN PSYCHIATRISCH ZIEKE PERSONEN IVZW (OTH) |
participant | ES | CIBER | CONSORCIO CENTRO DE INVESTIGACION BIOMEDICA EN RED M.P. (REC) |
participant | UK | ELI LILLY | Eli Lilly and Company Limited (PRC) |
participant | DE | BI | BOEHRINGER INGELHEIM INTERNATIONALGMBH (PRC) |
participant | BE | JANSSEN | JANSSEN PHARMACEUTICA NV (PRC) |
participant | CH | ROCHE | F. HOFFMANN-LA ROCHE AG (PRC) |
participant | CH | NOV | NOVARTIS PHARMA AG (PRC) |
participant | UK | UNEXE | THE UNIVERSITY OF EXETER (HES) |
participant | NL | UMCU | UNIVERSITAIR MEDISCH CENTRUM UTRECHT (HES) |
participant | NL | EMC | ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM (HES) |
coordinator | NL | RUG | RIJKSUNIVERSITEIT GRONINGEN (HES) |
participant | NL | LUMC | ACADEMISCH ZIEKENHUIS LEIDEN (HES) |
participant | NL | RUMC | STICHTING KATHOLIEKE UNIVERSITEIT (HES) |
participant | IT | UNIBO | ALMA MATER STUDIORUM - UNIVERSITA DI BOLOGNA (HES) |
Within the project PREFER this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
participant | DE | SPM | STEINBEISSER PROJECT MANAGEMENT UG (HAFTUNGSBESCHRANKT) (PRC) |
participant | DE | CSL | CSL BEHRING GMBH (PRC) |
participant | UK | MDUK | MUSCULAR DYSTROPHY GROUP OF GREAT BRITAIN AND NORTHERN IRELAND (OTH) |
participant | BE | MB | MINDBYTES (PRC) |
participant | UK | AbbVie | AbbVie Ltd (PRC) |
participant | UK | IAPO | INTERNATIONAL ALLIANCE OF PATIENT'ORGANIZATIONS (OTH) |
participant | UK | Amgen | AMGEN LIMITED (PRC) |
participant | BE | KCE | FEDERAAL KENNISCENTRUM VOOR DE GEZONDHEIDSZORG (REC) |
participant | UK | Takeda | TAKEDA DEVELOPMENT CENTRE EUROPE LTD (PRC) |
participant | US | MSD | MERCK SHARP & DOHME CORP (PRC) |
participant | BE | ECPC | EUROPEAN CANCER PATIENT COALITION (OTH) |
participant | IT | ITB | "INSTITUTO TUMORI ""GIOVANNI PAOLO II""" (REC) |
participant | NL | ASTELLAS | ASTELLAS PHARMA EUROPE BV (PRC) |
participant | UK | Lilly | Eli Lilly and Company Limited (PRC) |
participant | DE | Bayer | Bayer Pharma AG (PRC) |
participant | FR | SANOFI | SANOFI-AVENTIS RECHERCHE & DEVELOPPEMENT (PRC) |
participant | BE | JP | JANSSEN PHARMACEUTICA NV (PRC) |
participant | LU | EPF | FORUM EUROPEEN DES PATIENTS (FPE) (OTH) |
participant | CH | ROCHE | F. HOFFMANN-LA ROCHE AG (PRC) |
participant | CH | NVS | NOVARTIS PHARMA AG (PRC) |
participant | CH | Actelion | ACTELION PHARMACEUTICALS LTD (PRC) |
participant | NL | ERASMUS | ERASMUS UNIVERSITEIT ROTTERDAM (HES) |
participant | DE | UKER | UNIVERSITATSKLINIKUM ERLANGEN (HES) |
participant | UK | UoB | THE UNIVERSITY OF BIRMINGHAM (HES) |
participant | NL | UMCU | UNIVERSITAIR MEDISCH CENTRUM UTRECHT (HES) |
participant | SE | MEDIMMUNE | ASTRAZENECA AB (PRC) |
participant | DE | Merck | MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN (PRC) |
participant | IT | IEO | ISTITUTO EUROPEO DI ONCOLOGIA SRL (PRC) |
coordinator | SE | UU | UPPSALA UNIVERSITET (HES) |
participant | UK | UNEW | UNIVERSITY OF NEWCASTLE UPON TYNE (HES) |
participant | NL | EMC | ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM (HES) |
participant | BE | KUL | KATHOLIEKE UNIVERSITEIT LEUVEN (HES) |
Within the project RESCEU this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
participant | US | Novavax | NOVAVAX INC (PRC) |
participant | ES | SERGAS | SERVIZO GALEGO DE SAUDE (PUB) |
participant | ES | SYNAPSE | SYNAPSE RESEARCH MANAGEMENT PARTNERS SL (PRC) |
participant | BE | GKS | GLAXOSMITHKLINE BIOLOGICALS SA (PRC) |
participant | BE | JP | JANSSEN PHARMACEUTICA NV (PRC) |
participant | FI | TUCH | VARSINAIS-SUOMEN SAIRAANHOITOPIIRIN KUNTAYHTYMA (REC) |
participant | IT | PENTA | FONDAZIONE PENTA - FOR THE TREATMENT AND CARE OF CHILDREN WITH HIV ANDRELATED DISEASES - ONLUS (REC) |
participant | BE | UANTWERPEN | UNIVERSITEIT ANTWERPEN (HES) |
participant | NL | UMCG | ACADEMISCH ZIEKENHUIS GRONINGEN (HES) |
participant | NL | UMC UTRECHT | UNIVERSITAIR MEDISCH CENTRUM UTRECHT (HES) |
participant | DK | SSI | STATENS SERUM INSTITUT (REC) |
participant | SE | Astrazeneca | ASTRAZENECA AB (PRC) |
participant | FR | SP | SANOFI PASTEUR SA (PRC) |
coordinator | UK | UEDIN | THE UNIVERSITY OF EDINBURGH (HES) |
participant | UK | UOXF | THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD (HES) |
participant | NL | RIVM | RIJKSINSTITUUT VOOR VOLKSGEZONDHEID EN MILIEU (REC) |
participant | UK | Imperial | IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE (HES) |
Within the project DO-IT this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
participant | UK | HIQ | HEALTH IQ LIMITED (PRC) |
participant | UK | ABPI | THE ASSOCIATION OF THE BRITISH PHARMACEUTICAL INDUSTRY (OTH) |
participant | DE | Bayer | BAYER AKTIENGESELLSCHAFT (PRC) |
participant | SE | IHE | IHE, INSTITUTET FOR HALSO- OCH SJUKVARDSEKONOMI AKTIEBOLAG (PRC) |
participant | NO | NoMA | STATENS LEGEMIDDELVERK (PUB) |
participant | CH | Celgene | CELGENE MANAGEMENT SARL (PRC) |
participant | BE | UCB | UCB BIOPHARMA SRL (PRC) |
participant | BE | EFPIA | FEDERATION EUROPEENNE D'ASSOCIATIONS ET D'INDUSTRIES PHARMACEUTIQUES (OTH) |
participant | SE | TLV | TANDVARDS-OCH LAKEMEDELSFORMANSVERKET (PUB) |
participant | ES | FI | ASOCIACION NACIONAL EMPRESARIAL DE LA INDUSTRIA FARMACEUTICA (OTH) |
participant | DE | VFA | VERBAND FORSCHENDER ARZNEIMITTELHERSTELLER EV (OTH) |
participant | BE | EMSP | THE EUROPEAN MULTIPLE SCLEROSIS PLATFORM AISBL (OTH) |
participant | US | MSD | MERCK SHARP & DOHME CORP (PRC) |
participant | BE | ECPC | EUROPEAN CANCER PATIENT COALITION (OTH) |
participant | DE | TMF | TMF - TECHNOLOGIE UND METHODENPLATTFORM FUR DIE VERNETZTE MEDIZINISCHE FORSCHUNG EV (REC) |
participant | UK | NICE | NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE (PUB) |
participant | BE | Amgen | AMGEN (PRC) |
participant | UK | ELI LILLY | Eli Lilly and Company Limited (PRC) |
participant | FR | IRIS | INSTITUT DE RECHERCHES INTERNATIONALES SERVIER (PRC) |
participant | DE | InterSystems | INTERSYSTEMS GMBH (PRC) |
participant | FR | SARD | SANOFI-AVENTIS RECHERCHE & DEVELOPPEMENT (PRC) |
participant | DE | BI | BOEHRINGER INGELHEIM INTERNATIONALGMBH (PRC) |
participant | BE | JANSSEN | JANSSEN PHARMACEUTICA NV (PRC) |
participant | NO | NIPH | FOLKEHELSEINSTITUTTET (REC) |
participant | CH | ROCHE | F. HOFFMANN-LA ROCHE AG (PRC) |
participant | CH | NOV | NOVARTIS PHARMA AG (PRC) |
participant | IT | CERGAS | UNIVERSITA COMMERCIALE LUIGI BOCCONI (HES) |
participant | HU | SU | SEMMELWEIS EGYETEM (HES) |
coordinator | UK | LSE | LONDON SCHOOL OF ECONOMICS AND POLITICAL SCIENCE (HES) |
participant | UK | GSK | GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT LTD. (PRC) |
participant | DK | Novo | NOVO NORDISK A/S (PRC) |
participant | DE | Merck | MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN (PRC) |
participant | UK | ULIV | THE UNIVERSITY OF LIVERPOOL (HES) |
participant | UK | Imperial | IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE (HES) |
participant | FR | INSERM | INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (REC) |
Within the project IB4SD-TRISTAN this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
participant | SE | Antaros | ANTAROS MEDICAL AB (PRC) |
participant | SE | TRULY | TRULY LABS AB (PRC) |
participant | DE | Bruker | BRUKER BIOSPIN MRI GMBH (PRC) |
participant | UK | Bioxydyn | BIOXYDYN LIMITED (PRC) |
participant | DE | AbbVie | ABBVIE DEUTSCHLAND GMBH & CO KG (PRC) |
participant | US | MSD | MERCK SHARP & DOHME CORP (PRC) |
participant | DE | Sanofi | SANOFI-AVENTIS DEUTSCHLAND GMBH (PRC) |
participant | DE | Bayer | Bayer Pharma AG (PRC) |
coordinator | BE | EORTC | EUROPEAN ORGANISATION FOR RESEARCH AND TREATMENT OF CANCER AISBL (REC) |
participant | UK | GE | GE HEALTHCARE LIMITED (PRC) |
participant | FR | UB | UNIVERSITE DIJON BOURGOGNE (HES) |
participant | SE | ULUND | LUNDS UNIVERSITET (HES) |
participant | UK | UNIMAN | THE UNIVERSITY OF MANCHESTER (HES) |
participant | NL | UMCG | ACADEMISCH ZIEKENHUIS GRONINGEN (HES) |
participant | UK | GSK | GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT LTD. (PRC) |
participant | DK | Novo Nordisk | NOVO NORDISK A/S (PRC) |
participant | UK | ULEEDS | UNIVERSITY OF LEEDS (HES) |
participant | UK | UOS | THE UNIVERSITY OF SHEFFIELD (HES) |
participant | SE | CHALMERS | CHALMERS TEKNISKA HOEGSKOLA AB (HES) |
participant | NL | RUMC | STICHTING KATHOLIEKE UNIVERSITEIT (HES) |
Within the project ITCC-P4 this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
participant | DE | Bayer | BAYER AKTIENGESELLSCHAFT (PRC) |
participant | NL | PMC | PRINSES MAXIMA CENTRUM VOOR KINDERONCOLOGIE BV (OTH) |
participant | FR | ITCC | INNOVATIVE THERAPIES FOR CHILDREN WITH CANCER ASSOCIATION (REC) |
participant | FR | XenTech | XENTECH SAS (PRC) |
participant | DE | CR | CHARLES RIVER DISCOVERY RESEARCH SERVICES GERMANY GMBH (PRC) |
participant | DE | EPO | EXPERIMENTELLE PHARMAKOLOGIE UND ONKOLOGIE BERLIN-BUCH GMBH (PRC) |
participant | UK | Eli Lilly | Eli Lilly and Company Limited (PRC) |
participant | AT | CCRI | ST. ANNA KINDERKREBSFORSCHUNG (REC) |
participant | NL | AMC | ACADEMISCH MEDISCH CENTRUM BIJ DE UNIVERSITEIT VAN AMSTERDAM (HES) |
participant | FR | IGR | INSTITUT GUSTAVE ROUSSY (REC) |
participant | UK | ICR | THE INSTITUTE OF CANCER RESEARCH: ROYAL CANCER HOSPITAL (HES) |
participant | IT | ACC | ALLEANZA CONTRO IL CANCRO (OTH) |
participant | ES | FSJD | FUNDACIO SANT JOAN DE DEU (REC) |
participant | CH | ROCHE | F. HOFFMANN-LA ROCHE AG (PRC) |
participant | ES | PHARMAMAR | PHARMAMAR, S.A. (PRC) |
participant | FR | INSTITUT CURIE | INSTITUT CURIE (REC) |
participant | CH | UZH | UNIVERSITAT ZURICH (HES) |
participant | AT | MUW | MEDIZINISCHE UNIVERSITAET WIEN (HES) |
coordinator | DE | DKFZ | DEUTSCHES KREBSFORSCHUNGSZENTRUM HEIDELBERG (REC) |
participant | DE | CHARITE | CHARITE - UNIVERSITAETSMEDIZIN BERLIN (HES) |
Within the project EQIPD this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
participant | BE | Arlenda | PHARMALEX BELGIUM (PRC) |
participant | US | SE | SCIENCE EXCHANGE, INC. (PRC) |
participant | BE | Arlenda | ARLENDA SA (PRC) |
participant | DE | PAASP | PAASP GMBH (PRC) |
participant | NL | ECNP | STICHTING BURO ECNP (OTH) |
participant | US | PGI | PSYCHOGENICS INC (PRC) |
participant | BE | UCB | UCB BIOPHARMA SRL (PRC) |
participant | US | ABBVIE | ABBVIE INC (PRC) |
participant | FR | Porsolt | PORSOLT SAS (PRC) |
participant | DE | UMC-Mainz | UNIVERSITAETSMEDIZIN DER JOHANNES GUTENBERG-UNIVERSITAET MAINZ (HES) |
participant | DE | concentris | Concentris Research Management GmbH (PRC) |
participant | FR | SARD | SANOFI-AVENTIS RECHERCHE & DEVELOPPEMENT (PRC) |
participant | DE | BI | BOEHRINGER INGELHEIM INTERNATIONALGMBH (PRC) |
participant | BE | JANSSEN | JANSSEN PHARMACEUTICA NV (PRC) |
participant | NL | NOLDUS | NOLDUS INFORMATION TECHNOLOGY BV (PRC) |
participant | CH | ROCHE | F. HOFFMANN-LA ROCHE AG (PRC) |
participant | NL | Sylics | SYNAPTOLOGICS BV (PRC) |
participant | CH | NOV | NOVARTIS PHARMA AG (PRC) |
participant | FI | ORION | ORION OYJ (PRC) |
participant | UK | UniAbdn | THE UNIVERSITY COURT OF THE UNIVERSITY OF ABERDEEN (HES) |
participant | FR | Servier | INSTITUT DE RECHERCHES SERVIER (PRC) |
coordinator | UK | UEDIN | THE UNIVERSITY OF EDINBURGH (HES) |
participant | CH | UBERN | UNIVERSITAET BERN (HES) |
participant | DE | LMU MUENCHEN | LUDWIG-MAXIMILIANS-UNIVERSITAET MUENCHEN (HES) |
participant | NL | RUG | RIJKSUNIVERSITEIT GRONINGEN (HES) |
participant | DE | EKUT | EBERHARD KARLS UNIVERSITAET TUEBINGEN (HES) |
participant | NL | RUMC | STICHTING KATHOLIEKE UNIVERSITEIT (HES) |
participant | DE | CHARITE | CHARITE - UNIVERSITAETSMEDIZIN BERLIN (HES) |
participant | UK | Imperial | IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE (HES) |
Within the project RTCure this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
participant | SE | ANOCCA | ANOCCA AB (PRC) |
participant | BE | UCB | UCB BIOPHARMA SRL (PRC) |
participant | BE | API | APITOPE INTERNATIONAL NV (PRC) |
participant | DE | DRFZ | Deutsches Rheuma-Forschungszentrum Berlin (REC) |
participant | US | BMS | BRISTOL-MYERS SQUIBB COMPANY CORP (PRC) |
participant | DE | SANOFI | SANOFI-AVENTIS DEUTSCHLAND GMBH (PRC) |
participant | BE | JANSSEN | JANSSEN PHARMACEUTICA NV (PRC) |
participant | CH | IRB | FONDAZIONE PER L ISTITUTO DI RICERCA IN BIOMEDICINA (REC) |
participant | HU | SEMMELWEIS | SEMMELWEIS EGYETEM (HES) |
participant | DE | UKER | UNIVERSITATSKLINIKUM ERLANGEN (HES) |
participant | AU | UQ | THE UNIVERSITY OF QUEENSLAND (HES) |
participant | UK | UoB | THE UNIVERSITY OF BIRMINGHAM (HES) |
participant | UK | GSK | GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT LTD. (PRC) |
participant | UK | UGLA | UNIVERSITY OF GLASGOW (HES) |
coordinator | SE | KI | KAROLINSKA INSTITUTET (HES) |
participant | UK | KCL | KING'S COLLEGE LONDON (HES) |
participant | UK | UNEW | UNIVERSITY OF NEWCASTLE UPON TYNE (HES) |
participant | AT | MUW | MEDIZINISCHE UNIVERSITAET WIEN (HES) |
participant | NL | LUMC | ACADEMISCH ZIEKENHUIS LEIDEN (HES) |
Within the project LITMUS this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
participant | FR | ECHO | ECHOSENS (PRC) |
participant | SG | HI | HISTOINDEX PTE LTD (PRC) |
participant | US | RESO | RESOUNDANT, INC. (PRC) |
participant | UK | ICPT | INTERCEPT PHARMA EUROPE LTD (PRC) |
participant | DK | Ellegaard | ELLEGAARD GOTTINGEN MINIPIGS AS (PRC) |
participant | IL | EXA | EXALENZ BIOSCIENCE LTD (PRC) |
participant | SE | Antaros | ANTAROS MEDICAL AB (PRC) |
participant | DK | NB | NORDIC BIOSCIENCE A/S (PRC) |
participant | UK | PERS | PERSPECTUM LTD (PRC) |
participant | CH | EASL | EUROPEAN ASSOCIATION FOR THE STUDYOF THE LIVER (OTH) |
participant | UK | AGN | ALLERGAN LIMITED (PRC) |
participant | FR | ICAN | INST CARDIOMETABOLISME NUTRITION ICAN (REC) |
participant | UK | Takeda | TAKEDA DEVELOPMENT CENTRE EUROPE LTD (PRC) |
participant | ES | OWL | ONE WAY LIVER SL (PRC) |
participant | DK | NB | NORDIC BIOSCIENCE COMPOUND DEVELOPMENT A/S (PRC) |
participant | PT | FFUL | Faculdade de Farmácia da Universidade de Lisboa (HES) |
participant | US | GIL | GILEAD SCIENCES INC (PRC) |
participant | DE | UMCM | UNIVERSITAETSMEDIZIN DER JOHANNES GUTENBERG-UNIVERSITAET MAINZ (HES) |
participant | US | BMS | BRISTOL-MYERS SQUIBB COMPANY CORP (PRC) |
participant | BE | UZA | UNIVERSITAIR ZIEKENHUIS ANTWERPEN (REC) |
participant | DE | UKW | UNIVERSITAETSKLINIKUM WUERZBURG - KLINIKUM DER BAYERISCHEN JULIUS-MAXIMILIANS-UNIVERSITAT (HES) |
participant | UK | Lilly | Eli Lilly and Company Limited (PRC) |
participant | DE | SANOFI | SANOFI-AVENTIS DEUTSCHLAND GMBH (PRC) |
participant | US | SOMA | SOMALOGIC INC (PRC) |
participant | US | RTI-HS | RESEARCH TRIANGLE INSTITUTE (REC) |
participant | DE | BI | BOEHRINGER INGELHEIM INTERNATIONALGMBH (PRC) |
participant | LU | LIH | LUXEMBOURG INSTITUTE OF HEALTH (REC) |
participant | NL | AMC | ACADEMISCH MEDISCH CENTRUM BIJ DE UNIVERSITEIT VAN AMSTERDAM (HES) |
participant | ES | CIC | ASOCIACION CENTRO DE INVESTIGACION COOPERATIVA EN BIOCIENCIAS (REC) |
participant | ES | SAS | SERVICIO ANDALUZ DE SALUD (PUB) |
participant | EL | NKUA | ETHNIKO KAI KAPODISTRIAKO PANEPISTIMIO ATHINON (HES) |
participant | FR | APHP-SAMU | ASSISTANCE PUBLIQUE HOPITAUX DE PARIS (REC) |
participant | SE | ORU | OREBRO UNIVERSITY (HES) |
participant | FR | GNFT | GENFIT (PRC) |
participant | UK | IXS | IXSCIENT LIMITED (PRC) |
participant | IT | UNIPA | UNIVERSITA DEGLI STUDI DI PALERMO (HES) |
participant | CH | NVS | NOVARTIS PHARMA AG (PRC) |
participant | FR | UA | UNIVERSITE D'ANGERS (HES) |
participant | SE | LIU | LINKOPINGS UNIVERSITET (HES) |
participant | IT | UNITO | UNIVERSITA DEGLI STUDI DI TORINO (HES) |
participant | PT | FML | FACULDADE DE MEDICINA DA UNIVERSIDADE DE LISBOA (HES) |
participant | DE | UKAACHEN | UNIVERSITAETSKLINIKUM AACHEN (HES) |
participant | UK | BIM | THE UNIVERSITY OF BIRMINGHAM (HES) |
participant | NL | UMC UTRECHT | UNIVERSITAIR MEDISCH CENTRUM UTRECHT (HES) |
participant | IT | UCSC | UNIVERSITA CATTOLICA DEL SACRO CUORE (HES) |
participant | DK | Novo Nordisk | NOVO NORDISK A/S (PRC) |
participant | SE | AZ | ASTRAZENECA AB (PRC) |
participant | CH | UB | UNIVERSITAET BERN (HES) |
participant | UK | UoN | THE UNIVERSITY OF NOTTINGHAM (HES) |
participant | UK | UCAM | THE CHANCELLOR MASTERS AND SCHOLARSOF THE UNIVERSITY OF CAMBRIDGE (HES) |
participant | UK | UOXF | THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD (HES) |
coordinator | UK | UNEW | UNIVERSITY OF NEWCASTLE UPON TYNE (HES) |
participant | AT | MUW | MEDIZINISCHE UNIVERSITAET WIEN (HES) |
participant | FI | UH | HELSINGIN YLIOPISTO (HES) |
participant | IT | UMIL | UNIVERSITA DEGLI STUDI DI MILANO (HES) |
Within the project COMBACTE-CDI this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
participant | SI | NLZOH | NACIONALNI LABORATORIJ ZA ZDRAVJE, OKOLJE IN HRANO (REC) |
participant | FR | bMx | BIOMERIEUX SA (PRC) |
participant | BE | GKS | GLAXOSMITHKLINE BIOLOGICALS SA (PRC) |
participant | FR | DAV | DA VOLTERRA SAS (PRC) |
participant | IT | INMI | ISTITUTO NAZIONALE PER LE MALATTIE INFETTIVE LAZZARO SPALLANZANI-ISTITUTO DI RICOVERO E CURA A CARATTERE SCIENTIFICO (REC) |
participant | DE | UKK | KLINIKUM DER UNIVERSITAET ZU KOELN (HES) |
participant | BE | UANTWERPEN | UNIVERSITEIT ANTWERPEN (HES) |
coordinator | NL | UMC UTRECHT | UNIVERSITAIR MEDISCH CENTRUM UTRECHT (HES) |
participant | SE | Astrazeneca | ASTRAZENECA AB (PRC) |
participant | FR | SP | SANOFI PASTEUR SA (PRC) |
participant | UK | UNIVLEEDS | UNIVERSITY OF LEEDS (HES) |
participant | NL | LUMC | ACADEMISCH ZIEKENHUIS LEIDEN (HES) |
participant | DE | EKUT | EBERHARD KARLS UNIVERSITAET TUEBINGEN (HES) |
Within the project PARADIGM this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
participant | BE | Alexion | ALEXION SERVICES EUROPE SPRL (PRC) |
participant | CA | HTAi | HEALTH TECHNOLOGY ASSESSMENT INTERNATIONAL SOCIETY (OTH) |
participant | BE | Synergist | THE SYNERGIST (OTH) |
participant | UK | ABPI | THE ASSOCIATION OF THE BRITISH PHARMACEUTICAL INDUSTRY (OTH) |
participant | DE | Bayer AG | BAYER AKTIENGESELLSCHAFT (PRC) |
participant | BE | UCB | UCB BIOPHARMA SRL (PRC) |
participant | IT | AIFA | AGENZIA ITALIANA DEL FARMACO (PRC) |
participant | UK | Amgen | AMGEN LIMITED (PRC) |
participant | BE | EFPIA | FEDERATION EUROPEENNE D'ASSOCIATIONS ET D'INDUSTRIES PHARMACEUTIQUES (OTH) |
participant | NL | STICHTING VU | STICHTING VU (HES) |
participant | DE | VFA | VERBAND FORSCHENDER ARZNEIMITTELHERSTELLER EV (OTH) |
participant | FR | EURORDIS | EURORDIS - EUROPEAN ORGANISATION FOR RARE DISEASES ASSOCIATION (OTH) |
participant | DE | GRT | GRUNENTHAL GMBH (PRC) |
participant | UK | Covance | COVANCE LABORATORIES LTD (PRC) |
participant | US | MSD | MERCK SHARP & DOHME CORP (PRC) |
participant | ES | SYNAPSE | SYNAPSE RESEARCH MANAGEMENT PARTNERS SL (PRC) |
participant | UK | Eli Lilly | Eli Lilly and Company Limited (PRC) |
participant | FR | IRIS | INSTITUT DE RECHERCHES INTERNATIONALES SERVIER (PRC) |
participant | LU | AE | ALZHEIMER EUROPE (OTH) |
participant | FR | SARD | SANOFI-AVENTIS RECHERCHE & DEVELOPPEMENT (PRC) |
participant | BE | JANSSEN | JANSSEN PHARMACEUTICA NV (PRC) |
participant | ES | IACS | INSTITUTO ARAGONES DE CIENCIAS DE LA SALUD (REC) |
participant | DE | EATG | EUROPEAN AIDS TREATMENT GROUP EV (OTH) |
coordinator | LU | EPF | FORUM EUROPEEN DES PATIENTS (FPE) (OTH) |
participant | ES | FSJD | FUNDACIO SANT JOAN DE DEU (REC) |
participant | CH | ROCHE | F. HOFFMANN-LA ROCHE AG (PRC) |
participant | CH | NOVARTIS | NOVARTIS PHARMA AG (PRC) |
participant | DK | Lundbeck | H. LUNDBECK AS (PRC) |
participant | UK | GSK | GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT LTD. (PRC) |
participant | DK | Novo Nordisk | NOVO NORDISK A/S (PRC) |
participant | BE | EFGCP | EUROPEAN FORUM FOR GOOD CLINICAL PRACTICE (OTH) |
participant | DE | Merck | MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN (PRC) |
participant | UK | UOXF | THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD (HES) |
Within the project ReSOLUTE this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
participant | CH | VP | VIFOR (INTERNATIONAL) AG (PRC) |
participant | DE | Bayer AG | BAYER AKTIENGESELLSCHAFT (PRC) |
participant | FR | SARD | SANOFI-AVENTIS RECHERCHE & DEVELOPPEMENT (PRC) |
participant | DE | BI | BOEHRINGER INGELHEIM INTERNATIONALGMBH (PRC) |
participant | IT | AXXAM | AXXAM SPA (PRC) |
coordinator | AT | CeMM | CEMM - FORSCHUNGSZENTRUM FUER MOLEKULARE MEDIZIN GMBH (PRC) |
participant | CH | NOVARTIS | NOVARTIS PHARMA AG (PRC) |
participant | AT | UW-APRI | UNIVERSITAT WIEN (HES) |
participant | UK | UNIMAN | THE UNIVERSITY OF MANCHESTER (HES) |
participant | NL | ULEI | UNIVERSITEIT LEIDEN (HES) |
participant | UK | UOL | THE UNIVERSITY OF LIVERPOOL (HES) |
participant | UK | UOXF | THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD (HES) |
participant | DE | MPG | MAX-PLANCK-GESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN EV (REC) |
Within the project EFOEUPATI this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
participant | DE | Bayer AG | BAYER AKTIENGESELLSCHAFT (PRC) |
participant | BE | UCB | UCB BIOPHARMA SRL (PRC) |
participant | US | AbbVie | ABBVIE INC (PRC) |
participant | IE | IPPOSI | IRISH PLATFORM FOR PATIENTS' ORGANISATIONS SCIENCE AND INDUSTRY LIMITED BY GUARANTEE (OTH) |
participant | DE | EATG | EUROPEAN AIDS TREATMENT GROUP EV (OTH) |
coordinator | LU | EPF | FORUM EUROPEEN DES PATIENTS (FPE) (OTH) |
participant | CH | NOVARTIS | NOVARTIS PHARMA AG (PRC) |
participant | UK | GSK | GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT LTD. (PRC) |
participant | DK | Novo Nordisk | NOVO NORDISK A/S (PRC) |
participant | BE | EFGCP | EUROPEAN FORUM FOR GOOD CLINICAL PRACTICE (OTH) |
participant | DK | UCPH | KOBENHAVNS UNIVERSITET (HES) |
Within the project WEB-RADR 2 this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
participant | UK | SNOMED | INTERNATIONAL HEALTH TERMINOLOGY STANDARDS DEVELOPMENT ORGANISATION (OTH) |
participant | CH | ICH | THE INTERNATIONAL COUNCIL FOR HARMONISATION OF TECHNICAL REQUIREMENTS FOR PHARMACEUTICALS FOR HUMAN USE (OTH) |
participant | DK | DKMA | LAEGEMIDDELSTYRELSEN (PUB) |
participant | DE | CSL | CSL BEHRING GMBH (PRC) |
coordinator | UK | MHRA | MEDICINES AND HEALTHCARE PRODUCTS REGULATORY AGENCY (PUB) |
participant | US | AbbVie | ABBVIE INC (PRC) |
participant | NL | LAREB | STICHTING LAREB (REC) |
participant | SE | UMC | Stiftelsen WHO Collaborating Centre for International Drug Monitoring (REC) |
participant | ES | AEMPS | AGENCIA ESPANOLA DE MEDICAMENTOS Y PRODUCTOS SANITARIOS (PUB) |
participant | CH | NOVARTIS | NOVARTIS PHARMA AG (PRC) |
Within the project iConsensus this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
participant | DE | RB | RENTSCHLER BIOPHARMA SE (PRC) |
participant | NL | KAN | KANTISTO BV (PRC) |
participant | DE | PAIA | PAIA BIOTECH GMBH (PRC) |
participant | BE | ITC | IPRATECH SA (PRC) |
participant | DK | SVA | SVANHOLM.COM APS (PRC) |
participant | NL | SYNTHON | SYNTHON BIOPHARMACEUTICALS BV (PRC) |
participant | DE | Bayer AG | BAYER AKTIENGESELLSCHAFT (PRC) |
participant | FR | ISE | IPRASENSE (PRC) |
participant | BE | UCB | UCB BIOPHARMA SRL (PRC) |
participant | DE | M2P | M2P-LABS GMBH (PRC) |
participant | NL | MICRONIT | MICRONIT MICROTECHNOLOGIES BV (PRC) |
participant | BE | UMONS | UNIVERSITE DE MONS (HES) |
participant | DE | SANOFI | SANOFI-AVENTIS DEUTSCHLAND GMBH (PRC) |
participant | DE | PS | PRESENS PRECISION SENSING GMBH (PRC) |
participant | DE | UHOH | UNIVERSITAET HOHENHEIM (HES) |
participant | UK | GSK | GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT LTD. (PRC) |
participant | DE | RWTH | RHEINISCH-WESTFAELISCHE TECHNISCHE HOCHSCHULE AACHEN (HES) |
coordinator | SE | KTH | KUNGLIGA TEKNISKA HOEGSKOLAN (HES) |
Within the project c4c this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
participant | HU | MCRN-Hungary | GYERMEKGYOGYASZATI KLINIKAI VIZSGALOI HALOZAT (OTH) |
participant | DE | HSK | HELIOS DR. HORST SCHMIDT KLINIKEN WIESBADEN GMBH (PRC) |
participant | DE | Bayer | BAYER AKTIENGESELLSCHAFT (PRC) |
participant | AT | OKIDS | OKIDS GMBH (OTH) |
participant | NL | ECAPN-ECNP | ECNP RESEARCH AND SCHOLARSHIP STICHTING (DE ECNP RESEARCH AND SCHOLARSHIP FOUNDATION) (OTH) |
participant | BE | UCB | UCB BIOPHARMA SRL (PRC) |
participant | DK | ECFS | EUROPEAN CYSTIC FIBROSIS SOCIETY (OTH) |
participant | FR | ECRIN | ECRIN EUROPEAN CLINICAL RESEARCH INFRASTRUCTURE NETWORK (REC) |
participant | IT | FGB | FONDAZIONE PER LA RICERCA FARMACOLOGICA GIANNI BENZI ONLUS (REC) |
participant | CH | SCTO | SWISS CLINICAL TRIAL ORGANISATION (OTH) |
participant | FR | EURORDIS | EURORDIS - EUROPEAN ORGANISATION FOR RARE DISEASES ASSOCIATION (OTH) |
participant | IT | ARSENAL | ARSENAL.IT - CENTRO VENETO RICERCAE INNOVAZIONE PER LA SANITA DIGITALE (REC) |
participant | ES | CHUS | SERVIZO GALEGO DE SAUDE (PUB) |
participant | NO | HUS-Norway | HELSE BERGEN HF*HAUKELAND UNIVERSITY HOSPITAL (HES) |
participant | PT | AIDFM | Associação para Investigação e Desenvolvimento da Faculdade de Medicina (HES) |
participant | UK | Lilly | Eli Lilly and Company Limited (PRC) |
participant | FR | SERVIER | INSTITUT DE RECHERCHES INTERNATIONALES SERVIER (PRC) |
participant | BE | SIOPE | SIOP EUROPE ASBL (OTH) |
participant | FR | SANOFI | SANOFI-AVENTIS RECHERCHE & DEVELOPPEMENT (PRC) |
participant | BE | JANSSEN | JANSSEN PHARMACEUTICA NV (PRC) |
participant | DE | RBMF | ROBERT BOSCH GESELLSCHAFT FUR MEDIZINISCHE FORSCHUNG MBH (REC) |
participant | IT | OPBG | OSPEDALE PEDIATRICO BAMBINO GESU (OTH) |
participant | IT | IGG | ISTITUTO GIANNINA GASLINI (PUB) |
participant | FI | HUS | HELSINGIN JA UUDENMAAN SAIRAANHOITOPIIRIN KUNTAYHTYMÄ (REC) |
participant | PL | IPCZD | INSTYTUT POMNIK CENTRUM ZDROWIA DZIECKA (REC) |
coordinator | IT | PENTA | FONDAZIONE PENTA - FOR THE TREATMENT AND CARE OF CHILDREN WITH HIV ANDRELATED DISEASES - ONLUS (REC) |
participant | ES | FSJD | FUNDACIO SANT JOAN DE DEU (REC) |
participant | CH | ROCHE | F. HOFFMANN-LA ROCHE AG (PRC) |
participant | CH | NVS | NOVARTIS PHARMA AG (PRC) |
participant | DE | UKL-HD | UNIVERSITATSKLINIKUM HEIDELBERG (HES) |
participant | EE | UT | TARTU ULIKOOL (HES) |
participant | EL | AUTH | ARISTOTELIO PANEPISTIMIO THESSALONIKIS (HES) |
participant | CZ | CUNI | UNIVERZITA KARLOVA (HES) |
participant | UK | GSK | GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT LTD. (PRC) |
participant | UK | UCL | UNIVERSITY COLLEGE LONDON (HES) |
participant | IE | Tyndall - UCC | UNIVERSITY COLLEGE CORK - NATIONAL UNIVERSITY OF IRELAND, CORK (HES) |
participant | SE | KI | KAROLINSKA INSTITUTET (HES) |
participant | UK | UNILIV | THE UNIVERSITY OF LIVERPOOL (HES) |
participant | UK | UNEW | UNIVERSITY OF NEWCASTLE UPON TYNE (HES) |
participant | BE | UGent | UNIVERSITEIT GENT (HES) |
participant | NL | SKU | STICHTING KATHOLIEKE UNIVERSITEIT (HES) |
participant | FR | INSERM | INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (REC) |
Within the project IM2PACT this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
participant | US | FCDI | FUJIFILM CELLULAR DYNAMICS INC (PRC) |
participant | DE | Neuway Pharma | NEUWAY PHARMA GMBH (PRC) |
participant | NL | STICHTING VUMC | STICHTING VUMC (REC) |
participant | NL | ARTEMIS | ARTEMIS BIO-SUPPORT B.V. (PRC) |
participant | NL | MIMETAS BV | MIMETAS BV (PRC) |
participant | HU | PHI | PHARMACOIDEA FEJLESZTO ES SZOLGALTATO KFT (PRC) |
participant | DE | UMC-Mainz | UNIVERSITAETSMEDIZIN DER JOHANNES GUTENBERG-UNIVERSITAET MAINZ (HES) |
participant | DE | UKW | UNIVERSITAETSKLINIKUM WUERZBURG - KLINIKUM DER BAYERISCHEN JULIUS-MAXIMILIANS-UNIVERSITAT (HES) |
participant | FR | SARD | SANOFI-AVENTIS RECHERCHE & DEVELOPPEMENT (PRC) |
participant | BE | JANSSEN | JANSSEN PHARMACEUTICA NV (PRC) |
participant | DE | TiHo | STIFTUNG TIERAERZTLICHE HOCHSCHULE HANNOVER (HES) |
participant | AT | AIT | AIT AUSTRIAN INSTITUTE OF TECHNOLOGY GMBH (REC) |
participant | CH | NOVARTIS | NOVARTIS PHARMA AG (PRC) |
participant | IT | UNIMORE | UNIVERSITA DEGLI STUDI DI MODENA E REGGIO EMILIA (HES) |
participant | DK | Lundbeck | H. LUNDBECK AS (PRC) |
participant | UK | OU | THE OPEN UNIVERSITY (HES) |
participant | DK | Novo Nordisk | NOVO NORDISK A/S (PRC) |
participant | UK | UNIVDUN | UNIVERSITY OF DUNDEE (HES) |
participant | UK | USFD | THE UNIVERSITY OF SHEFFIELD (HES) |
participant | UK | CU | CARDIFF UNIVERSITY (HES) |
coordinator | UK | UOXF | THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD (HES) |
participant | SE | UU | UPPSALA UNIVERSITET (HES) |
participant | DE | UHEI | RUPRECHT-KARLS-UNIVERSITAET HEIDELBERG (HES) |
participant | NL | LUMC | ACADEMISCH ZIEKENHUIS LEIDEN (HES) |
participant | DK | UCPH | KOBENHAVNS UNIVERSITET (HES) |
participant | DK | AU | AARHUS UNIVERSITET (HES) |
Within the project EHDEN this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
participant | CZ | Odysseus | ODYSSEUS DATA SERVICES SRO (PRC) |
participant | UK | ICHOM | INTERNATIONAL CONSORTIUM FOR HEALTHOUTCOMES MEASUREMENT LTD (OTH) |
participant | DE | Bayer | BAYER AKTIENGESELLSCHAFT (PRC) |
participant | CH | Celgene | CELGENE MANAGEMENT SARL (PRC) |
participant | BE | UCB | UCB BIOPHARMA SRL (PRC) |
participant | US | ABBVIE | ABBVIE INC (PRC) |
participant | NL | THE HYVE | THE HYVE BV (PRC) |
participant | UK | NICE | NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE (PUB) |
participant | ES | SYNAPSE | SYNAPSE RESEARCH MANAGEMENT PARTNERS SL (PRC) |
participant | UK | ELI LILLY | Eli Lilly and Company Limited (PRC) |
participant | FR | IRIS | INSTITUT DE RECHERCHES INTERNATIONALES SERVIER (PRC) |
participant | SE | UMC | Stiftelsen WHO Collaborating Centre for International Drug Monitoring (REC) |
participant | FR | SARD | SANOFI-AVENTIS RECHERCHE & DEVELOPPEMENT (PRC) |
participant | BE | JANSSEN | JANSSEN PHARMACEUTICA NV (PRC) |
participant | LU | EPF | FORUM EUROPEEN DES PATIENTS (FPE) (OTH) |
participant | CH | NOV | NOVARTIS PHARMA AG (PRC) |
participant | PT | UAVR | UNIVERSIDADE DE AVEIRO (HES) |
participant | EE | TARTU | TARTU ULIKOOL (HES) |
participant | SE | AZ | ASTRAZENECA AB (PRC) |
participant | UK | UOXF | THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD (HES) |
coordinator | NL | EMC | ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM (HES) |
Within the project VITAL this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
participant | RS | MiHA | MIHAJLOVIC JOVAN (PRC) |
participant | ES | FISABIO | FUNDACION PARA EL FOMENTO DE LA INVESTIGACION SANITARIA Y BIOMEDICA DE LA COMUNITAT VALENCIANA (REC) |
participant | BE | EFPIA | FEDERATION EUROPEENNE D'ASSOCIATIONS ET D'INDUSTRIES PHARMACEUTIQUES (OTH) |
participant | HU | SYREON | SYREON KUTATO INTEZET KORLATOLT FELELOSSEGU TARSASAG (PRC) |
participant | BE | P95 | P95 CVBA (PRC) |
participant | NL | JAN | JANSSEN VACCINES & PREVENTION BV (PRC) |
participant | FR | bMx | BIOMERIEUX SA (PRC) |
participant | US | MSD | MERCK SHARP & DOHME CORP (PRC) |
participant | BE | GSK Bio | GLAXOSMITHKLINE BIOLOGICALS SA (PRC) |
participant | NO | NIPH | FOLKEHELSEINSTITUTTET (REC) |
participant | IT | UNIFE | UNIVERSITA DEGLI STUDI DI FERRARA (HES) |
participant | AT | ACINN | UNIVERSITAET INNSBRUCK (HES) |
participant | FR | UJM | UNIVERSITE JEAN MONNET SAINT-ETIENNE (HES) |
participant | NL | UMCG | ACADEMISCH ZIEKENHUIS GRONINGEN (HES) |
coordinator | NL | UMCU | UNIVERSITAIR MEDISCH CENTRUM UTRECHT (HES) |
participant | DK | SSI | STATENS SERUM INSTITUT (REC) |
participant | FR | SP | SANOFI PASTEUR SA (PRC) |
participant | UK | UCL | UNIVERSITY COLLEGE LONDON (HES) |
participant | IT | ISS | ISTITUTO SUPERIORE DI SANITA (REC) |
participant | NL | RIVM | RIJKSINSTITUUT VOOR VOLKSGEZONDHEID EN MILIEU (REC) |
participant | UK | Imperial | IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE (HES) |
participant | FR | INSERM | INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (REC) |
participant | FR | CNRS | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE CNRS (REC) |
Within the project NeuroDeRisk this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
participant | US | FCDI | FUJIFILM CELLULAR DYNAMICS INC (PRC) |
participant | FR | UCA | UNIVERSITE CLERMONT AUVERGNE (HES) |
participant | RS | UNIBEO | FARMACEUTSKI FAKULTET UNIVERZITETAU BEOGRADU (HES) |
participant | BE | UCB | UCB BIOPHARMA SRL (PRC) |
participant | FR | ALCEDIAG | ALCEDIAG (PRC) |
participant | US | MSD | MERCK SHARP & DOHME CORP (PRC) |
participant | EL | BIOVISTA | A. PERSIDIS & SIA OE (PRC) |
participant | FI | UEF | ITA-SUOMEN YLIOPISTO (HES) |
participant | FR | SARD | SANOFI-AVENTIS RECHERCHE & DEVELOPPEMENT (PRC) |
participant | PT | ICETA | ICETA INSTITUTO DE CIENCIAS, TECNOLOGIAS E AGROAMBIENTE DA UNIVERSIDADE DO PORTO (REC) |
participant | AT | IL | INTE:LIGAND SOFTWARE-ENTWICKLUNGS-UND CONSULTING GMBH (PRC) |
participant | CH | NOVARTIS | NOVARTIS PHARMA AG (PRC) |
coordinator | AT | UW-APRI | UNIVERSITAT WIEN (HES) |
participant | IT | CRIACIV LABIMA | UNIVERSITA DEGLI STUDI DI FIRENZE (HES) |
participant | SE | MEDIMMUNE | ASTRAZENECA AB (PRC) |
participant | SE | UU | UPPSALA UNIVERSITET (HES) |
participant | AT | MUW | MEDIZINISCHE UNIVERSITAET WIEN (HES) |
Within the project BIOMAP this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
participant | FI | TUT | TAMPEREEN KORKEAKOULUSAATIO SR (HES) |
participant | LU | ITTM | INFORMATION TECHNOLOGY FOR TRANSLATIONAL MEDICINE (ITTM) SA (PRC) |
participant | BE | UCB | UCB BIOPHARMA SRL (PRC) |
participant | DK | LEO PHARMA | LEO PHARMA AS (PRC) |
participant | DK | COPSAC | DEN SELVEJENDE INSTITUTION DANSK BORNEASTMA CENTER (OTH) |
participant | FI | UEF | ITA-SUOMEN YLIOPISTO (HES) |
participant | DE | SANOFI | SANOFI-AVENTIS DEUTSCHLAND GMBH (PRC) |
participant | DE | BI | BOEHRINGER INGELHEIM INTERNATIONALGMBH (PRC) |
participant | NL | AMC | ACADEMISCH MEDISCH CENTRUM BIJ DE UNIVERSITEIT VAN AMSTERDAM (HES) |
participant | DE | HS | HAHN-SCHICKARD-GESELLSCHAFT FUER ANGEWANDTE FORSCHUNG E.v. (REC) |
participant | AT | AIT | AIT AUSTRIAN INSTITUTE OF TECHNOLOGY GMBH (REC) |
participant | CH | CHUV | CENTRE HOSPITALIER UNIVERSITAIRE VAUDOIS (PUB) |
participant | DE | EURICE | EURICE EUROPEAN RESEARCH AND PROJECT OFFICE GMBH (PRC) |
coordinator | DE | CAU | CHRISTIAN-ALBRECHTS-UNIVERSITAET ZU KIEL (HES) |
participant | IE | TCD | THE PROVOST, FELLOWS, FOUNDATION SCHOLARS & THE OTHER MEMBERS OF BOARD OF THE COLLEGE OF THE HOLY & UNDIVIDED TRINITY OF QUEEN ELIZABETH NEAR DUBLIN (HES) |
participant | DE | UDUS | HEINRICH-HEINE-UNIVERSITAET DUESSELDORF (HES) |
participant | DE | UKE | UNIVERSITAETSKLINIKUM HAMBURG-EPPENDORF (HES) |
participant | AT | UNIVIE | UNIVERSITAT WIEN (HES) |
participant | DE | TUM-MED | KLINIKUM RECHTS DER ISAR DER TECHNISCHEN UNIVERSITAT MUNCHEN (HES) |
participant | LU | uni.lu | UNIVERSITE DU LUXEMBOURG (HES) |
participant | EE | UTARTU | TARTU ULIKOOL (HES) |
participant | FI | UTA | TAMPEREEN YLIOPISTO (HES) |
participant | UK | LSHTM | LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE ROYAL CHARTER (HES) |
participant | UK | UNIVBRIS | UNIVERSITY OF BRISTOL (HES) |
participant | UK | UNIVDUN | UNIVERSITY OF DUNDEE (HES) |
participant | DE | TUM | TECHNISCHE UNIVERSITAET MUENCHEN (HES) |
participant | SE | KI | KAROLINSKA INSTITUTET (HES) |
participant | UK | KCL | KING'S COLLEGE LONDON (HES) |
participant | NL | LUMC | ACADEMISCH ZIEKENHUIS LEIDEN (HES) |
participant | DK | UCPH | KOBENHAVNS UNIVERSITET (HES) |
participant | NL | RUMC | STICHTING KATHOLIEKE UNIVERSITEIT (HES) |
Within the project TransBioLine this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
participant | DE | Signatope | SIGNATOPE GMBH (PRC) |
participant | LU | ITTM | INFORMATION TECHNOLOGY FOR TRANSLATIONAL MEDICINE (ITTM) SA (PRC) |
participant | DE | METAHEPS | METAHEPS GMBH (PRC) |
participant | AT | TAM | TAMIRNA GMBH (PRC) |
participant | DE | MLM | MLM MEDICAL LABS GMBH (PRC) |
participant | DE | ABX CRO | ABX CRO ADVANCED PHARMACEUTICAL SERVICES FORSCHUNGSGESELLSCHAFT MBH (PRC) |
participant | US | MSD | MERCK SHARP & DOHME CORP (PRC) |
participant | ES | SYNAPSE | SYNAPSE RESEARCH MANAGEMENT PARTNERS SL (PRC) |
participant | UK | Lilly | Eli Lilly and Company Limited (PRC) |
participant | FR | SARD | SANOFI-AVENTIS RECHERCHE & DEVELOPPEMENT (PRC) |
participant | BE | JANSSEN | JANSSEN PHARMACEUTICA NV (PRC) |
participant | ES | SAS | SERVICIO ANDALUZ DE SALUD (PUB) |
participant | ES | IR-HSCSP | FUNDACIO PRIVADA INSTITUT DE RECERCA DE L'HOSPITAL DE LA SANTA CREU I SANT PAU (REC) |
participant | CH | ROCHE | F. HOFFMANN-LA ROCHE AG (PRC) |
participant | FR | AP-HP | ASSISTANCE PUBLIQUE HOPITAUX DE PARIS (REC) |
participant | CH | NOVARTIS | NOVARTIS PHARMA AG (PRC) |
participant | IS | LANDSPITALI | LANDSPITALI UNIVERSITY HOSPITAL (HES) |
participant | ES | USAL | UNIVERSIDAD DE SALAMANCA (HES) |
participant | ES | UMA | UNIVERSIDAD DE MALAGA (HES) |
participant | NL | ULEI | UNIVERSITEIT LEIDEN (HES) |
coordinator | CH | UZH | UNIVERSITAT ZURICH (HES) |
participant | UK | UNOT | THE UNIVERSITY OF NOTTINGHAM (HES) |
participant | DE | LMU MUENCHEN | LUDWIG-MAXIMILIANS-UNIVERSITAET MUENCHEN (HES) |
participant | UK | ULIV | THE UNIVERSITY OF LIVERPOOL (HES) |
participant | UK | UNEW | UNIVERSITY OF NEWCASTLE UPON TYNE (HES) |
participant | DE | Charite | CHARITE - UNIVERSITAETSMEDIZIN BERLIN (HES) |
Within the project MOBILISE-D this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
participant | US | ERT | ERESEARCH TECHNOLOGY INC (PRC) |
participant | DE | PRI | PENUMOLOGISCHES FORSCHUNGSINSTITUTAN DER LUNGENCLINIC GROSSHANSDORF GMBH (PRC) |
participant | DE | BAY | BAYER AKTIENGESELLSCHAFT (PRC) |
participant | IL | TEV | TEVA PHARMACEUTICAL INDUSTRIES LIMITED (PRC) |
participant | IE | ICR | ICON CLINICAL RESEARCH LIMITED (PRC) |
participant | UK | Amgen | AMGEN LIMITED (PRC) |
participant | ES | ISGLOBAL | FUNDACION PRIVADA INSTITUTO DE SALUD GLOBAL BARCELONA (REC) |
participant | DE | GRT | GRUNENTHAL GMBH (PRC) |
participant | NL | McR | MCROBERTS BV (PRC) |
participant | UK | TAKEDA | TAKEDA DEVELOPMENT CENTRE EUROPE LTD (PRC) |
participant | IL | TASMC | THE FOUNDATION FOR MEDICAL RESEARCH INFRASTRUCTURAL DEVELOPMENT AND HEALTH SERVICES NEXT TO THE MEDICAL CENTER TEL AVIV (REC) |
participant | FR | SARD | SANOFI-AVENTIS RECHERCHE & DEVELOPPEMENT (PRC) |
participant | DE | RBMF | ROBERT BOSCH GESELLSCHAFT FUR MEDIZINISCHE FORSCHUNG MBH (REC) |
participant | IT | UNISS | UNIVERSITA DEGLI STUDI DI SASSARI (HES) |
participant | FR | CHUM | CENTRE HOSPITALIER UNIVERSITAIRE MONTPELLIER (OTH) |
participant | UK | IXS | IXSCIENT LIMITED (PRC) |
participant | CH | NOVARTIS | NOVARTIS PHARMA AG (PRC) |
participant | DE | CAU | CHRISTIAN-ALBRECHTS-UNIVERSITAET ZU KIEL (HES) |
participant | IT | USR | UNIVERSITA VITA-SALUTE SAN RAFFAELE (HES) |
participant | UK | UNN | UNIVERSITY OF NORTHUMBRIA AT NEWCASTLE (HES) |
participant | DE | UKER | UNIVERSITATSKLINIKUM ERLANGEN (HES) |
participant | SE | MEDIMMUNE | ASTRAZENECA AB (PRC) |
participant | DE | Merck | MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN (PRC) |
participant | CH | EPFL | ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE (HES) |
participant | IE | UCD | UNIVERSITY COLLEGE DUBLIN, NATIONAL UNIVERSITY OF IRELAND, DUBLIN (HES) |
participant | CH | UZH | UNIVERSITAT ZURICH (HES) |
participant | UK | USFD | THE UNIVERSITY OF SHEFFIELD (HES) |
participant | NO | NTNU | NORGES TEKNISK-NATURVITENSKAPELIGE UNIVERSITET NTNU (HES) |
coordinator | UK | UNEW | UNIVERSITY OF NEWCASTLE UPON TYNE (HES) |
participant | BE | KU Leuven | KATHOLIEKE UNIVERSITEIT LEUVEN (HES) |
participant | UK | Imperial | IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE (HES) |
participant | IT | UNIBO | ALMA MATER STUDIORUM - UNIVERSITA DI BOLOGNA (HES) |
participant | DE | 01ZL FAU FAPS | FRIEDRICH-ALEXANDER-UNIVERSITAET ERLANGEN NUERNBERG (HES) |
Within the project ConcePTION this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
participant | NL | ORC | ORCION BV (PRC) |
participant | BE | Bionotus | BIONOTUS (PRC) |
participant | NL | ENTIS | STICHTING ENTIS (EUROPEAN NETWORK TERATOLOGY INFORMATION SERVICES) FOUNDATION (OTH) |
participant | BE | Synergist | THE SYNERGIST (OTH) |
participant | DK | Ellegaard | ELLEGAARD GOTTINGEN MINIPIGS AS (PRC) |
participant | BE | i-HD | THE EUROPEAN INSTITUTE FOR INNOVATION THROUGH HEALTH DATA (REC) |
participant | IL | Teva | TEVA PHARMACEUTICAL INDUSTRIES LIMITED (PRC) |
participant | UK | MHRA | MEDICINES AND HEALTHCARE PRODUCTS REGULATORY AGENCY (PUB) |
participant | BE | UCB | UCB BIOPHARMA SRL (PRC) |
participant | NL | Elevate | ELEVATE BV (PRC) |
participant | AT | BBMRI-ERIC | BIOBANKS AND BIOMOLECULAR RESOURCES RESEARCH INFRASTRUCTURE CONSORTIUM (BBMRI-ERIC) (REC) |
participant | US | AbbVie | ABBVIE INC (PRC) |
participant | NL | TTOP | TTOPSTART BV (PRC) |
participant | ES | FISABIO | FUNDACION PARA EL FOMENTO DE LA INVESTIGACION SANITARIA Y BIOMEDICA DE LA COMUNITAT VALENCIANA (REC) |
participant | UK | Takeda | TAKEDA DEVELOPMENT CENTRE EUROPE LTD (PRC) |
participant | UK | Covance | COVANCE LABORATORIES LTD (PRC) |
participant | US | BMS | BRISTOL-MYERS SQUIBB COMPANY CORP (PRC) |
participant | FI | THL | TERVEYDEN JA HYVINVOINNIN LAITOS (REC) |
participant | UK | Lilly | Eli Lilly and Company Limited (PRC) |
participant | IE | EIWH | EUROPEAN INSTITUTE OF WOMEN'S HEALTH COMPANY LIMITED BY GUARANTEE (REC) |
participant | NL | EMA | THE EUROPEAN MEDICINES AGENCY (PUB) |
participant | NL | LAREB | STICHTING LAREB (REC) |
participant | FR | SANOFI | SANOFI-AVENTIS RECHERCHE & DEVELOPPEMENT (PRC) |
participant | BE | JANSSEN | JANSSEN PHARMACEUTICA NV (PRC) |
participant | SE | SCC | REGION STOCKHOLM (PUB) |
participant | UK | NUTH | THE NEWCASTLE UPON TYNE HOSPITALS NHS FOUNDATION TRUST (PUB) |
participant | IT | ARS | AGENZIA REGIONALE DI SANITA (OTH) |
participant | CH | NVS | NOVARTIS PHARMA AG (PRC) |
participant | IT | UNIFE | UNIVERSITA DEGLI STUDI DI FERRARA (HES) |
participant | UK | USWAN | SWANSEA UNIVERSITY (HES) |
participant | UK | SGUL | ST GEORGE'S HOSPITAL MEDICAL SCHOOL (HES) |
participant | UK | Ulster | UNIVERSITY OF ULSTER (HES) |
participant | ZA | UKZN | UNIVERSITY OF KWAZULU-NATAL (HES) |
participant | FR | CHUT | CENTRE HOSPITALIER UNIVERSITAIRE DE TOULOUSE (HES) |
participant | UK | UNIMAN | THE UNIVERSITY OF MANCHESTER (HES) |
participant | NL | UMCG | ACADEMISCH ZIEKENHUIS GRONINGEN (HES) |
coordinator | NL | UMC UTRECHT | UNIVERSITAIR MEDISCH CENTRUM UTRECHT (HES) |
participant | UK | GSK | GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT LTD. (PRC) |
participant | DK | Novo Nordisk | NOVO NORDISK A/S (PRC) |
participant | BE | EFGCP | EUROPEAN FORUM FOR GOOD CLINICAL PRACTICE (OTH) |
participant | DE | Merck | MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN (PRC) |
participant | CH | UNIGE | UNIVERSITE DE GENEVE (HES) |
participant | NO | UiO | UNIVERSITETET I OSLO (HES) |
participant | SE | KI | KAROLINSKA INSTITUTET (HES) |
participant | IT | CNR | CONSIGLIO NAZIONALE DELLE RICERCHE (REC) |
participant | SE | UU | UPPSALA UNIVERSITET (HES) |
participant | BE | KU Leuven | KATHOLIEKE UNIVERSITEIT LEUVEN (HES) |
participant | NL | RIVM | RIJKSINSTITUUT VOOR VOLKSGEZONDHEID EN MILIEU (REC) |
participant | IT | UNIBO | ALMA MATER STUDIORUM - UNIVERSITA DI BOLOGNA (HES) |
participant | FR | INSERM | INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (REC) |
Within the project EBiSC2 this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
participant | US | FCDI | FUJIFILM CELLULAR DYNAMICS INC (PRC) |
participant | DE | Bayer | BAYER AKTIENGESELLSCHAFT (PRC) |
participant | BE | UCB | UCB BIOPHARMA SRL (PRC) |
participant | UK | Takeda | TAKEDA DEVELOPMENT CENTRE EUROPE LTD (PRC) |
participant | UK | DH | Department of Health (REC) |
participant | UK | Lilly | Eli Lilly and Company Limited (PRC) |
participant | BE | JAN | JANSSEN PHARMACEUTICA NV (PRC) |
participant | DK | BiP | BIONEER A/S (REC) |
participant | FR | ART | ARTTIC (PRC) |
participant | DK | LUB | H. LUNDBECK AS (PRC) |
participant | DK | NOVO | NOVO NORDISK A/S (PRC) |
participant | FR | Servier | INSTITUT DE RECHERCHES SERVIER (PRC) |
coordinator | DE | 01V FHG | FRAUNHOFER GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E.V. (REC) |
participant | BE | KU Leuven | KATHOLIEKE UNIVERSITEIT LEUVEN (HES) |
participant | DE | Charité | CHARITE - UNIVERSITAETSMEDIZIN BERLIN (HES) |
Within the project Trials@Home this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
participant | FR | IQVIA | IQVIA RDS FRANCE (PRC) |
participant | BE | Covance | COVANCE CLINICAL AND PERIAPPROVAL SERVICES (PRC) |
participant | UK | MRN | MEDICAL RESEARCH NETWORK LIMITED (PRC) |
participant | UK | eClinicalHealth | ECLINICALHEALTH LTD (PRC) |
participant | NL | MLCF | STICHTING MLC FOUNDATION (OTH) |
participant | DE | Bayer | BAYER AKTIENGESELLSCHAFT (PRC) |
participant | IL | TEVA | TEVA PHARMACEUTICAL INDUSTRIES LIMITED (PRC) |
participant | FR | DREEM | DREEM (PRC) |
participant | NL | UPPMD | STICHTING UNITED PARENT PROJECTS MUSCULAR DYSTROPHY (OTH) |
participant | BE | UCB | UCB BIOPHARMA SRL (PRC) |
participant | UK | Allergan | ALLERGAN LIMITED (PRC) |
participant | BE | VT | VITAL TRANSFORMATION (PRC) |
participant | CH | Medtronic | MEDTRONIC INTERNATIONAL TRADING SARL (PRC) |
participant | ES | FISABIO | FUNDACION PARA EL FOMENTO DE LA INVESTIGACION SANITARIA Y BIOMEDICA DE LA COMUNITAT VALENCIANA (REC) |
participant | UK | Takeda | TAKEDA DEVELOPMENT CENTRE EUROPE LTD (PRC) |
participant | NL | JCR | JULIUS CLINICAL RESEARCH BV (PRC) |
participant | NL | Lygature | STICHTING LYGATURE (OTH) |
participant | FR | SARD | SANOFI-AVENTIS RECHERCHE & DEVELOPPEMENT (PRC) |
participant | DE | BI Pharma | BOEHRINGER INGELHEIM INTERNATIONALGMBH (PRC) |
participant | BE | JANSSEN | JANSSEN PHARMACEUTICA NV (PRC) |
participant | EL | CERTH | ETHNIKO KENTRO EREVNAS KAI TECHNOLOGIKIS ANAPTYXIS (REC) |
participant | AT | JOANNEUM | FH JOANNEUM GESELLSCHAFT MBH (HES) |
participant | CH | Novartis | NOVARTIS PHARMA AG (PRC) |
participant | DK | SDU | SYDDANSK UNIVERSITET (HES) |
coordinator | NL | UMCU | UNIVERSITAIR MEDISCH CENTRUM UTRECHT (HES) |
participant | SE | AZ | ASTRAZENECA AB (PRC) |
participant | BE | IDF Europe | FEDERATION INTERNATIONALE DU DIABETE REGION EUROPE AISBL (OTH) |
participant | UK | UNIVDUN | UNIVERSITY OF DUNDEE (HES) |
participant | UK | UOXF | THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD (HES) |
participant | NL | UU | UNIVERSITEIT UTRECHT (HES) |
Within the project 3TR this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
participant | IT | SIP Service | SIP SERVICE S.R.L. (PRC) |
participant | FR | SPLF | SOCIETE DE PNEUMOLOGIE DE LANGUE FRANCAISE (OTH) |
participant | NL | VUmc | STICHTING VUMC (REC) |
participant | UK | OWLSTONE | OWLSTONE MEDICAL LIMITED (PRC) |
participant | UK | LUPUS EUROPE | LUPUS EUROPE (OTH) |
participant | ES | ATRYS | ATRYS HEALTH, SA (PRC) |
participant | UK | Takeda | TAKEDA DEVELOPMENT CENTRE EUROPE LTD (PRC) |
participant | BE | UZGent | UNIVERSITAIR ZIEKENHUIS GENT (REC) |
participant | HR | GENOS | GENOS DOO ZA VJESTACENJE I ANALIZU (PRC) |
participant | DE | ALACRIS | ALACRIS THERANOSTICS GMBH (PRC) |
participant | DE | DRFZ | Deutsches Rheuma-Forschungszentrum Berlin (REC) |
participant | ES | CIBER | CONSORCIO CENTRO DE INVESTIGACION BIOMEDICA EN RED M.P. (REC) |
participant | UK | ELF | EUROPEAN LUNG FOUNDATION (OTH) |
participant | BE | E.F.A. | EUROPEAN FEDERATION OF ASTHMA &ALLERGY ASSOCIATIONS IDEELL FORENING (OTH) |
participant | DE | SANOFI | SANOFI-AVENTIS DEUTSCHLAND GMBH (PRC) |
participant | BE | JANSSEN | JANSSEN PHARMACEUTICA NV (PRC) |
coordinator | ES | FPS | FUNDACION PUBLICA ANDALUZA PROGRESO Y SALUD (REC) |
participant | NL | AMC | ACADEMISCH MEDISCH CENTRUM BIJ DE UNIVERSITEIT VAN AMSTERDAM (HES) |
participant | BE | CUSL | CLINIQUES UNIVERSITAIRES SAINT-LUC (REC) |
participant | IT | AOUMEYER | AZIENDA OSPEDALIERO-UNIVERSITARIA ANNA MEYER (REC) |
participant | ES | SAS | SERVICIO ANDALUZ DE SALUD (PUB) |
participant | FR | CHU NANCY | CENTRE HOSPITALIER REGIONAL UNIVERSITAIRE NANCY (HES) |
participant | CH | ERS | EUROPEAN RESPIRATORY SOCIETY (OTH) |
participant | ES | SUMMA | SERVICIO MADRILENO DE SALUD (PUB) |
participant | IT | IRCCS | FONDAZIONE IRCCS CA' GRANDA - OSPEDALE MAGGIORE POLICLINICO (OTH) |
participant | ES | CRG | FUNDACIO CENTRE DE REGULACIO GENOMICA (REC) |
participant | CH | ROCHE | F. HOFFMANN-LA ROCHE AG (PRC) |
participant | ES | IDIBAPS | CONSORCI INSTITUT D'INVESTIGACIONS BIOMEDIQUES AUGUST PI I SUNYER (OTH) |
participant | SE | ORU | OREBRO UNIVERSITY (HES) |
participant | BE | VIB | VIB (REC) |
participant | DK | REGIONH | REGION HOVEDSTADEN (PUB) |
participant | CH | NVS | NOVARTIS PHARMA AG (PRC) |
participant | DE | EURICE | EURICE EUROPEAN RESEARCH AND PROJECT OFFICE GMBH (PRC) |
participant | PT | iMM | INSTITUTO DE MEDICINA MOLECULAR JOAO LOBO ANTUNES (REC) |
participant | DE | CAU | CHRISTIAN-ALBRECHTS-UNIVERSITAET ZU KIEL (HES) |
participant | IT | UNICA | UNIVERSITA DEGLI STUDI DI CAGLIARI (HES) |
participant | UK | QMUL | QUEEN MARY UNIVERSITY OF LONDON (HES) |
participant | DE | UMR | PHILIPPS UNIVERSITAET MARBURG (HES) |
participant | IT | UNIPI | UNIVERSITA DI PISA (HES) |
participant | IT | UNICT | UNIVERSITA DEGLI STUDI DI CATANIA (HES) |
participant | BE | UHASSELT | UNIVERSITEIT HASSELT (HES) |
participant | DE | MHH | MEDIZINISCHE HOCHSCHULE HANNOVER (HES) |
participant | PL | LODZ | UNIVERSYTET MEDYCZNY W LODZI. (HES) |
participant | IT | AOPD | AZIENDA OSPEDALE UNIVERSITA PADOVA (PUB) |
participant | DE | TUD | TECHNISCHE UNIVERSITAET DRESDEN (HES) |
participant | FR | UBO | UNIVERSITE DE BRETAGNE OCCIDENTALE (HES) |
participant | UK | UNIMAN | THE UNIVERSITY OF MANCHESTER (HES) |
participant | IT | UNIPMN | UNIVERSITA DEGLI STUDI DEL PIEMONTE ORIENTALE AMEDEO AVOGADRO (HES) |
participant | CH | UNIBAS | UNIVERSITAT BASEL (HES) |
participant | NL | UMCG | ACADEMISCH ZIEKENHUIS GRONINGEN (HES) |
participant | UK | GSK | GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT LTD. (PRC) |
participant | SE | AZ | ASTRAZENECA AB (PRC) |
participant | UK | UGLA | UNIVERSITY OF GLASGOW (HES) |
participant | IE | UCD | UNIVERSITY COLLEGE DUBLIN, NATIONAL UNIVERSITY OF IRELAND, DUBLIN (HES) |
participant | NO | UiB | UNIVERSITETET I BERGEN (HES) |
participant | UK | SOUTHAMPTON | UNIVERSITY OF SOUTHAMPTON (HES) |
participant | UK | UCL | UNIVERSITY COLLEGE LONDON (HES) |
participant | IT | UNIGE | UNIVERSITA DEGLI STUDI DI GENOVA (HES) |
participant | UK | UCAM | THE CHANCELLOR MASTERS AND SCHOLARSOF THE UNIVERSITY OF CAMBRIDGE (HES) |
participant | SE | KI | KAROLINSKA INSTITUTET (HES) |
participant | UK | ULEIC | UNIVERSITY OF LEICESTER (HES) |
participant | DE | MPL | MAX-PLANCK-GESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN EV (REC) |
participant | BE | KU Leuven | KATHOLIEKE UNIVERSITEIT LEUVEN (HES) |
participant | ES | CSIC | AGENCIA ESTATAL CONSEJO SUPERIOR DEINVESTIGACIONES CIENTIFICAS (REC) |
participant | UK | QUB | THE QUEEN'S UNIVERSITY OF BELFAST (HES) |
participant | DE | CHARITE | CHARITE - UNIVERSITAETSMEDIZIN BERLIN (HES) |
participant | UK | Imperial | IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE (HES) |
participant | FR | INSERM | INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (REC) |
Within the project Immune-Image this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
participant | NL | Lawrencium | LAWRENCIUM LEGAL BV (PRC) |
participant | US | ImaginAb | IMAGINAB, INC (PRC) |
participant | SE | Antaros | ANTAROS MEDICAL AB (PRC) |
participant | DE | Bayer | BAYER AKTIENGESELLSCHAFT (PRC) |
coordinator | NL | VUmc | STICHTING VUMC (REC) |
participant | NL | TTOP | TTOPSTART BV (PRC) |
participant | UK | Takeda | TAKEDA DEVELOPMENT CENTRE EUROPE LTD (PRC) |
participant | BE | ECPC | EUROPEAN CANCER PATIENT COALITION (OTH) |
participant | ES | VHIO | FUNDACIO PRIVADA INSTITUT D'INVESTIGACIO ONCOLOGICA DE VALL-HEBRON (REC) |
participant | NL | LYG | STICHTING LYGATURE (OTH) |
participant | BE | JANSSEN | JANSSEN PHARMACEUTICA NV (PRC) |
participant | ES | VHIR | FUNDACIO HOSPITAL UNIVERSITARI VALL D'HEBRON - INSTITUT DE RECERCA (REC) |
participant | CH | ROCHE | F. HOFFMANN-LA ROCHE AG (PRC) |
participant | BE | VIB | VIB (REC) |
participant | CH | NVS | NOVARTIS PHARMA AG (PRC) |
participant | DE | WWU | WESTFAELISCHE WILHELMS-UNIVERSITAET MUENSTER (HES) |
participant | BE | VUB | VRIJE UNIVERSITEIT BRUSSEL (HES) |
participant | NL | UMCG | ACADEMISCH ZIEKENHUIS GRONINGEN (HES) |
participant | UK | UCAM | THE CHANCELLOR MASTERS AND SCHOLARSOF THE UNIVERSITY OF CAMBRIDGE (HES) |
participant | DE | EKUT | EBERHARD KARLS UNIVERSITAET TUEBINGEN (HES) |
participant | FR | CEA | COMMISSARIAT A L ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES (REC) |
Within the project EU-PEARL this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
participant | DE | Otsuka | OTSUKA NOVEL PRODUCTS GMBH (PRC) |
participant | US | CTF | CHILDREN'S TUMOR FOUNDATION (REC) |
participant | US | SpringWorks | SPRINGWORKS THERAPEUTICS INC (PRC) |
participant | DE | EUROSCAN | EUROSCAN INTERNATIONAL NETWORK EV (REC) |
participant | EE | DocuMental | DOCUMENTAL OU (PRC) |
participant | BE | i-HD | THE EUROPEAN INSTITUTE FOR INNOVATION THROUGH HEALTH DATA (REC) |
participant | IL | TEVA | TEVA PHARMACEUTICAL INDUSTRIES LIMITED (PRC) |
participant | NL | EATRIS | EATRIS ERIC (REC) |
participant | UK | BERRY | BERRY CONSULTANTS LLP (PRC) |
participant | UK | AGN | ALLERGAN LIMITED (PRC) |
participant | FR | ECRIN | ECRIN EUROPEAN CLINICAL RESEARCH INFRASTRUCTURE NETWORK (REC) |
participant | ES | SYNAPSE | SYNAPSE RESEARCH MANAGEMENT PARTNERS SL (PRC) |
participant | US | TB Alliance | GLOBAL ALLIANCE FOR TB DRUG DEVELOPMENT NON PROFIT ORGANISATION (REC) |
participant | FR | Servier | INSTITUT DE RECHERCHES INTERNATIONALES SERVIER (PRC) |
participant | FR | SARD | SANOFI-AVENTIS RECHERCHE & DEVELOPPEMENT (PRC) |
participant | DE | PEI | BUNDESINSTITUT FUR IMPFSTOFFE UND BIOMEDIZINISCHE ARZNEIMITTEL (PUB) |
participant | BE | JPNV | JANSSEN PHARMACEUTICA NV (PRC) |
participant | LU | EPF | FORUM EUROPEEN DES PATIENTS (FPE) (OTH) |
coordinator | ES | VHIR | FUNDACIO HOSPITAL UNIVERSITARI VALL D'HEBRON - INSTITUT DE RECERCA (REC) |
participant | FR | AP-HP | ASSISTANCE PUBLIQUE HOPITAUX DE PARIS (REC) |
participant | BE | CUSTODIX | CUSTODIX NV (PRC) |
participant | CH | NOVARTIS | NOVARTIS PHARMA AG (PRC) |
participant | IT | UNISR | UNIVERSITA VITA-SALUTE SAN RAFFAELE (HES) |
participant | UK | UMAN | THE UNIVERSITY OF MANCHESTER (HES) |
participant | DK | Novo | NOVO NORDISK A/S (PRC) |
participant | SE | Astrazeneca | ASTRAZENECA AB (PRC) |
participant | DE | LMU MUENCHEN | LUDWIG-MAXIMILIANS-UNIVERSITAET MUENCHEN (HES) |
participant | UK | KCL | KING'S COLLEGE LONDON (HES) |
participant | UK | UOXF | THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD (HES) |
participant | UK | UNEW | UNIVERSITY OF NEWCASTLE UPON TYNE (HES) |
participant | NL | EMC | ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM (HES) |
participant | AT | MUW | MEDIZINISCHE UNIVERSITAET WIEN (HES) |
participant | BE | KU Leuven | KATHOLIEKE UNIVERSITEIT LEUVEN (HES) |
participant | DE | CHARITE | CHARITE - UNIVERSITAETSMEDIZIN BERLIN (HES) |
participant | IT | UMIL | UNIVERSITA DEGLI STUDI DI MILANO (HES) |
Within the project IDEA-FAST this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
participant | UK | MBS | MEDIBIOSENSE LTD (PRC) |
participant | BE | BYTE | BYTEFLIES (PRC) |
participant | PT | FC.ID | FCIENCIAS.ID - ASSOCIACAO PARA A INVESTIGACAO E DESENVOLVIMENTO DE CIENCIAS (REC) |
participant | NL | MLCF | STICHTING MLC FOUNDATION (OTH) |
participant | IT | PLUR | PLURIBUS ONE SRL (PRC) |
participant | FR | DREEM | DREEM (PRC) |
participant | BE | EFCCA | EUROPEAN FEDERATION OF CROHN'S AND ULCERATIVE COLITIS ASSOCIATIONS (OTH) |
participant | FI | VTT | Teknologian tutkimuskeskus VTT Oy (REC) |
participant | BE | UCB | UCB BIOPHARMA SRL (PRC) |
participant | FR | ECRIN | ECRIN EUROPEAN CLINICAL RESEARCH INFRASTRUCTURE NETWORK (REC) |
participant | DE | GHI | GEORGE-HUNTINGTON-INSTITUT GMBH (PRC) |
participant | US | ABBV | ABBVIE INC (PRC) |
participant | UK | BIOGEN | BIOGEN IDEC LIMITED (PRC) |
participant | UK | PUK | PARKINSON'S DISEASE SOCIETY OF THEUNITED KINGDOM LBG (OTH) |
participant | FR | LIXOFT | LIXOFT SAS (PRC) |
participant | ES | APM | ASOCIACION PARKINSON MADRID (OTH) |
participant | NL | McR | MCROBERTS BV (PRC) |
participant | UK | TAK | TAKEDA DEVELOPMENT CENTRE EUROPE LTD (PRC) |
participant | DE | TMF | TMF - TECHNOLOGIE UND METHODENPLATTFORM FUR DIE VERNETZTE MEDIZINISCHE FORSCHUNG EV (REC) |
participant | UK | CCL | CAMBRIDGE COGNITION LIMITED (PRC) |
participant | NO | SUH | HELSE STAVANGER HF (OTH) |
participant | UK | Lilly | Eli Lilly and Company Limited (PRC) |
participant | FR | SARD | SANOFI-AVENTIS RECHERCHE & DEVELOPPEMENT (PRC) |
participant | BE | JANSSEN | JANSSEN PHARMACEUTICA NV (PRC) |
participant | PL | IPIN | INSTYTUT PSYCHIATRII I NEUROLOGII (REC) |
participant | CH | ROCHE | F. HOFFMANN-LA ROCHE AG (PRC) |
participant | UK | IXS | IXSCIENT LIMITED (PRC) |
participant | FI | ORION | ORION OYJ (PRC) |
participant | DE | EMP | EMPIRICA GESELLSCHAFT FUR KOMMUNIKATIONS UND TECHNOLOGIEFORSCHUNG MBH (PRC) |
participant | IE | UL | UNIVERSITY OF LIMERICK (HES) |
participant | PT | IMM | INSTITUTO DE MEDICINA MOLECULAR JOAO LOBO ANTUNES (REC) |
participant | DE | UKSH | UNIVERSITATSKLINIKUM SCHLESWIG-HOLSTEIN (HES) |
participant | UK | QMUL | QUEEN MARY UNIVERSITY OF LONDON (HES) |
participant | FR | IMT | INSTITUT MINES-TELECOM (HES) |
participant | AT | MUI | MEDIZINISCHE UNIVERSITAT INNSBRUCK (HES) |
participant | ES | UAM | UNIVERSIDAD AUTONOMA DE MADRID (HES) |
participant | IT | UNIBS | UNIVERSITA DEGLI STUDI DI BRESCIA (HES) |
participant | UK | UoM | THE UNIVERSITY OF MANCHESTER (HES) |
participant | SE | AZN | ASTRAZENECA AB (PRC) |
participant | UK | UGLAS | UNIVERSITY OF GLASGOW (HES) |
participant | UK | UCAM | THE CHANCELLOR MASTERS AND SCHOLARSOF THE UNIVERSITY OF CAMBRIDGE (HES) |
coordinator | UK | UNEW | UNIVERSITY OF NEWCASTLE UPON TYNE (HES) |
participant | NL | EMC | ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM (HES) |
participant | NL | LUMC | ACADEMISCH ZIEKENHUIS LEIDEN (HES) |
participant | UK | ICL | IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE (HES) |
Within the project ImmUniverse this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
participant | LU | ITTM | INFORMATION TECHNOLOGY FOR TRANSLATIONAL MEDICINE (ITTM) SA (PRC) |
participant | BE | EFCCA | EUROPEAN FEDERATION OF CROHN'S AND ULCERATIVE COLITIS ASSOCIATIONS (OTH) |
coordinator | IT | HUNIMED | HUMANITAS UNIVERSITY (HES) |
participant | BE | EFA | EUROPEAN FEDERATION OF ASTHMA &ALLERGY ASSOCIATIONS IDEELL FORENING (OTH) |
participant | UK | Lilly | Eli Lilly and Company Limited (PRC) |
participant | DE | Sanofi | SANOFI-AVENTIS DEUTSCHLAND GMBH (PRC) |
participant | NL | AMC | ACADEMISCH MEDISCH CENTRUM BIJ DE UNIVERSITEIT VAN AMSTERDAM (HES) |
participant | LU | EPF | FORUM EUROPEEN DES PATIENTS (FPE) (OTH) |
participant | FR | CHRU | CENTRE HOSPITALIER REGIONAL UNIVERSITAIRE NANCY (HES) |
participant | AT | AIT | AIT AUSTRIAN INSTITUTE OF TECHNOLOGY GMBH (REC) |
participant | DK | AUH | AARHUS UNIVERSITETSHOSPITAL (REC) |
participant | BE | VIB | VIB VZW (REC) |
participant | CH | NVS | NOVARTIS PHARMA AG (PRC) |
participant | DE | EURICE | EURICE EUROPEAN RESEARCH AND PROJECT OFFICE GMBH (PRC) |
participant | DE | CAU | CHRISTIAN-ALBRECHTS-UNIVERSITAET ZU KIEL (HES) |
participant | LU | UNILU | UNIVERSITE DU LUXEMBOURG (HES) |
participant | IT | SSSA | SCUOLA SUPERIORE DI STUDI UNIVERSITARI E DI PERFEZIONAMENTO S ANNA (HES) |
participant | UK | GSK | GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT LTD. (PRC) |
participant | UK | UCAM | THE CHANCELLOR MASTERS AND SCHOLARSOF THE UNIVERSITY OF CAMBRIDGE (HES) |
participant | DE | LMU | LUDWIG-MAXIMILIANS-UNIVERSITAET MUENCHEN (HES) |
participant | IT | ISS | ISTITUTO SUPERIORE DI SANITA (REC) |
participant | AT | JRF | JOANNEUM RESEARCH FORSCHUNGSGESELLSCHAFT MBH (REC) |
participant | BE | KU Leuven | KATHOLIEKE UNIVERSITEIT LEUVEN (HES) |
participant | NL | RUMC | STICHTING KATHOLIEKE UNIVERSITEIT (HES) |
participant | DK | AU | AARHUS UNIVERSITET (HES) |
Within the project PharmaLedger this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
participant | PT | HES | HOSPITAL DO ESPIRITO SANTO DE EVORA EPE (PUB) |
participant | PT | INCM | IMPRENSA NACIONAL - CASA DA MOEDA, S. A. (PRC) |
participant | DE | BAYER | BAYER AKTIENGESELLSCHAFT (PRC) |
participant | BE | UCB | UCB BIOPHARMA SRL (PRC) |
participant | IL | AVO | ARTEEVO TECHNOLOGIES LTD (PRC) |
participant | US | ABBV | ABBVIE INC (PRC) |
participant | UK | TVS | TECHNOVATIVE SOLUTIONS LTD (PRC) |
participant | UK | ONO | ONORACH LTD (PRC) |
participant | US | MSD | MERCK SHARP & DOHME CORP (PRC) |
participant | DE | UKW | UNIVERSITAETSKLINIKUM WUERZBURG - KLINIKUM DER BAYERISCHEN JULIUS-MAXIMILIANS-UNIVERSITAT (HES) |
participant | BE | JANSSEN | JANSSEN PHARMACEUTICA NV (PRC) |
participant | EL | CERTH | ETHNIKO KENTRO EREVNAS KAI TECHNOLOGIKIS ANAPTYXIS (REC) |
participant | IL | EKN | EKON MODELING SOFWARE SYSTEMS LTD*EKON (PRC) |
participant | IT | OPB | OSPEDALE PEDIATRICO BAMBINO GESU (OTH) |
participant | LU | EPF | FORUM EUROPEEN DES PATIENTS (FPE) (OTH) |
participant | RO | INCDTCI ICSI | NATIONAL RESEARCH AND DEVELOPMENT INSTITUTE FOR CRYOGENICS AND ISOTOPIC TECHNOLOGIES ICSI RM VALCEA (REC) |
participant | CH | ROCHE | F. HOFFMANN-LA ROCHE AG (PRC) |
participant | EL | DUT | DIMOKRITIO PANEPISTIMIO THRAKIS (HES) |
participant | PT | PDM | PDM E FC PROJECTO DESENVOLVIMENTO MANUTENCAO FORMACAO E CONSULTADORIALDA (PRC) |
participant | CH | NVS | NOVARTIS PHARMA AG (PRC) |
participant | RO | RMS | ROMSOFT SRL (PRC) |
participant | UK | GSK | GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT LTD. (PRC) |
participant | DK | NOVO | NOVO NORDISK A/S (PRC) |
participant | SE | AZN | ASTRAZENECA AB (PRC) |
participant | BE | EFGCP | EUROPEAN FORUM FOR GOOD CLINICAL PRACTICE (OTH) |
coordinator | ES | UPM | UNIVERSIDAD POLITECNICA DE MADRID (HES) |
participant | BE | KU Leuven | KATHOLIEKE UNIVERSITEIT LEUVEN (HES) |